WORK Medical Technology Group (NASDAQ:WOK – Get Free Report) and 908 Devices (NASDAQ:MASS – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, valuation, institutional ownership, risk and dividends.
Profitability
This table compares WORK Medical Technology Group and 908 Devices’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| WORK Medical Technology Group | N/A | N/A | N/A |
| 908 Devices | -62.40% | -14.03% | -10.40% |
Volatility and Risk
WORK Medical Technology Group has a beta of 2.37, suggesting that its share price is 137% more volatile than the S&P 500. Comparatively, 908 Devices has a beta of 0.57, suggesting that its share price is 43% less volatile than the S&P 500.
Earnings & Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| WORK Medical Technology Group | $9.81 million | 0.00 | -$1.07 million | N/A | N/A |
| 908 Devices | $56.20 million | 4.90 | $19.49 million | ($1.00) | -7.28 |
908 Devices has higher revenue and earnings than WORK Medical Technology Group.
Analyst Ratings
This is a summary of current recommendations and price targets for WORK Medical Technology Group and 908 Devices, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| WORK Medical Technology Group | 1 | 0 | 0 | 0 | 1.00 |
| 908 Devices | 1 | 0 | 1 | 0 | 2.00 |
908 Devices has a consensus target price of $12.00, suggesting a potential upside of 64.84%. Given 908 Devices’ stronger consensus rating and higher probable upside, analysts clearly believe 908 Devices is more favorable than WORK Medical Technology Group.
Institutional & Insider Ownership
88.1% of 908 Devices shares are held by institutional investors. 28.2% of 908 Devices shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Summary
908 Devices beats WORK Medical Technology Group on 8 of the 12 factors compared between the two stocks.
About WORK Medical Technology Group
WORK Medical Technology Group Ltd. engages in developing health instruments. It manufactures and sells medical devices, including endotracheal tubes, laryngeal mask airways, heat and moisture exchanging filters, disposable breathing circuits, nebulizer kits, and yankauer suction sets. The company was founded on March 1, 2022 and is headquartered in Hangzhou, China.
About 908 Devices
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Receive News & Ratings for WORK Medical Technology Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WORK Medical Technology Group and related companies with MarketBeat.com's FREE daily email newsletter.
